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Abstract
Objective To study the effects of oromucosal
detomidine gel administered sublingually to calves
prior to disbudding, and to compare its efficacy with
intravenously (IV) administered detomidine.
Study design Randomised, prospective clinical study.
Animals Twenty dairy calves aged 12.4  4.4
days (mean  SD), weight 50.5  9.0 kg.
Methods Detomidine at 80 lg kg1 was adminis-
tered to ten calves sublingually (GEL) and at
30 lg kg1 to ten control calves IV (V. jugularis).
Meloxicam (0.5 mg kg1) and local anaesthetic
(lidocaine 3 mg kg1) were administered before
heat cauterization of horn buds. Heart rate (HR),
body temperature and clinical sedation were mon-
itored over 240 minutes. Blood was collected from
the V. cephalica during the same period for drug
concentration analysis. Pharmacokinetic variables
were calculated from the plasma detomidine con-
centration-time data using non-compartmental
methods. Statistical analyses compared routes of
administration by Student’s t-test and linear mixed
models as relevant.
Results The maximum plasma detomidine concen-
tration after GEL was 2.1  1.2 ng mL1 (mean 
SD) and the time of maximum concentration was
66.0  36.9 minutes. The bioavailability of detom-
idine was approximately 34% with GEL. Similar
sedation scores were reached in both groups after
administration of detomidine, but maximal sedation
was reached earlier in the IV group (10 minutes)
than in the GEL group (40 minutes). HR was lower
after IV than GEL from 5 to 10 minutes after
administration. All animals were adequately
sedated, and we were able to administer local
anaesthetic without resistance to all of the calves
before disbudding.
Conclusions and clinical relevance Oromucosally
administered detomidine is an effective sedative
agent for calves prior to disbudding.
Keywords calves, detomidine, disbudding, oromuco-
sal, sedatives, welfare.
Introduction
Disbudding, the removal of calves’ horn buds, is a
common procedure in dairy animal husbandry, but
the procedure causes severe acute pain, and is
associated with behavioural and physiological
responses (Morisse et al. 1995; McMeekan et al.
1998; Stafford & Mellor 2011). There is no EU
legislation for pain management associated with
disbudding. The European Council Directive 98/58/
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EC (1976) allows any skilled person to destroy or
remove the horn-producing area of calves aged
<4 weeks by chemical or heat cauterization.
Application of appropriate anaesthetics and anal-
gesics is not compulsory in most countries but it is
strongly recommended (AVA 2004; New Zealand
Government 2005; AVMA 2012). Cornual nerve
block and ring block around the horn buds with
local anaesthetics effectively alleviates disbudding
pain or delays its onset (Graf & Senn 1999; Fierheller
et al. 2012). However infiltration of local anaesthet-
ics to non-sedated calves is often difficult. Disbud-
ding-related postoperative pain has been successfully
alleviated by non-steroidal anti-inflammatory drugs,
such as meloxicam (Stewart et al. 2009; Heinrich
et al. 2010), ketoprofen (McMeekan et al. 1998;
Faulkner & Weary 2000) and carprofen (Stilwell
et al. 2012).
Despite recommendations, pain and distress
related to disbudding of calves often remains
untreated (Hoe & Ruegg 2006; Vasseur et al.
2010; Gottardo et al. 2011). According to the
ALCASDE (2009), it is assumed that some kind of
medical treatment is administered prior to or after
calf disbudding only on 20% of European farms. In
Italy, producers reported that 10% of their disbudded
calves received local anaesthetics, 4% received a
sedative and 5% received analgesics prior to disbud-
ding (Gottardo et al. 2011). In Canada, use of
sedatives or local anaesthetics was reported for
45% of herds, but no analgesics (NSAIDs) were
mentioned (Vasseur et al. 2010). In the United
States, sedatives or local anaesthetics were utilized
by 12% and analgesics by 2% of dairy farmers
(Fulwider et al. 2008).
Detomidine is a potent a2-adrenoceptor agonist
that is used commonly for sedation or premedica-
tion in horses and cattle, including calves (Peshin
et al. 1991). Sublingual administration of an oro-
mucosal gel formulation of detomidine produced
safe sedation in horses (DiMaio Knych & Stanley
2011; Kaukinen et al. 2011), and the bioavailabil-
ity was approximately 22% (Kaukinen et al. 2011).
The primary objective of this study was to explore
the use of oromucosal detomidine gel for sedation of
calves prior to disbudding. Our hypothesis was that
oromucosal detomidine would produce sufficient
sedation to allow administration of local anaesthet-
ics with minimum resistance. The secondary objec-
tive was to determine the plasma detomidine
concentrations after sublingual administration and
to compare level of sedation to intravenous (IV)
administration of detomidine in calves undergoing
disbudding.
Materials and methods
This study was conducted with permissions of the
Animal Experiment Board of Finland and the Finnish
Medicines Agency. Twenty clinically healthy dairy
calves of both sexes were included. Their age was
12.4  4.4 days (mean  SD) and they weighed
50.5  9.0 kg. The animals were disbudded as a
routine measure of the farm. The calves were housed
as other calves on the farm, and they were used to
human handling. The calves were allocated ran-
domly to one of two groups of 10 animals in each.
One group was given sublingually (GEL) detomidine
gel (Domosedan Gel 7.6 mg mL1 oromucosal gel;
Orion Pharma Ltd., Finland) 80 lg kg1, the other
group was given IV detomidine (Domosedan
10 mg mL1 solution for injection; Orion Pharma
Ltd.) 30 lg kg1.
Prior to drug administration, the calves were
examined clinically and the V. cephalica was cann-
ulated (16 G Intraflon, 1.6 9 60 mm; Vygon,
France) for blood sampling. In the IV group, the
V. jugularis was also cannulated with a similar
catheter for drug administration. Before placement
of the catheters, local anaesthesia was provided by
the subcutaneous infiltration of lidocaine (Lidocain
20 mg mL1; Orion Pharma Ltd.).
The detomidine gel for sublingual administration
was drawn into a 1 mL syringe to achieve an
accurate dose, and was administered under the
tongue of the calf. The IV detomidine was given as a
bolus via the jugular catheter, which thereafter was
flushed with 10 mL of isotonic saline. To alleviate
postoperative pain, meloxicam (0.5 mg kg1; Melo-
vem 5 mg mL1; Orion Pharma Ltd.) was adminis-
tered subcutaneously. When clinical sedation was
evident, the local anaesthetic, Lidocaine
20 mg mL1, was injected subcutaneously around
the cornual nerve and a ring block was inserted
around both horn buds as previously described by
Faulkner & Weary (2000). The total dose of
lidocaine was 3 mg kg1 per calf. The animal’s
response to administration of the local anaesthetic
was recorded. The adequacies of the local blocks
were tested with needle pricks, and once adequate,
hot cauterization was used to destroy the horn buds.
Heart rate (HR) was measured by auscultation
and the depth of sedation was recorded using a 17-
point (0–16 where 0 is no sedation) behaviour-based
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clinical sedation score (CSS) which was modified
from Kuusela et al. (2001). Details are presented as
supporting information (Appendix S1). The CSS was
recorded at 14 time points for 240 minutes after
drug administration.
Rectal temperature was measured with a digital
thermometer prior to treatment and every 30 min-
utes thereafter. The pen of the calf had a soft
insulated floor with a mattress and adequate saw-
dust. Calves were covered with blankets to maintain
the body temperature. The ambient temperature in
the pens was 10.0–19.4 °C during the study.
Venous blood samples (3 mL) were collected from
the catheter in the V. cephalica into EDTA tubes for
analysis of plasma detomidine concentrations. Times
of collection were, for the IV group at 5, 10, 20, 30,
60, 120, 180, 240 minutes, and for the GEL group
at 30, 60, 90, 120, 150, 180, 210, 240 minutes
after drug administration. After each sampling the
catheter was flushed with 5 mL of isotonic saline
with heparin (10 IU mL1). Samples were stored at
room temperature prior to centrifugation. Plasma
was separated by centrifugation (3000 g for
15 minutes) within three hours after sampling,
frozen and stored at 20 °C until analysis.
Quantitative analysis of detomidine concentra-
tions in plasma was performed with reversed phase
liquid chromatography (Shimadzu Prominence
HPLC instrument; Shimadzu Corporation, Japan)
combined with mass spectrometric detection (AB
Sciex API4000 triple quadrupole mass spectrometer,
Framingham, MA, USA) using an internal standard
method. Details are presented in the supporting
information, Appendix S2.
Pharmacokinetic variables were calculated from
the plasma detomidine concentration-time data with
the WinNonlin Professional software package, ver-
sion 5.3 (Pharsight Corporation, CA, USA) using
non-compartmental methods. The areas under the
time plasma concentration curve (AUC) and time
sedation score curve (AUCsed) were calculated with
the trapezoidal method. Bioavailability of detomidine
after sublingual administration was approximated
by using the formula 100% * AUCSL(avg)/AUCIV
(avg) * DIV/DSL, where D was the dose of detomidine.
The AUCs and the maximum sedation scores
detected for each animal were compared between
administration routes using Student’s t-test. The
differences between administration routes in CSS
and HR were compared with linear mixed models
taking repeated samplings into account. Fixed fac-
tors were the sampling time, administration route
and interaction between them. A calf was used as a
random factor. Statistical analyses were performed
using PASW 18.0.1 (SPSS Inc., IL, USA). p < 0.05
was considered statistically significant.
Results
Plasma detomidine concentrations are shown in
Fig. 1. The maximum plasma detomidine concen-
tration (Cmax) after sublingual administration was
2.1  1.2 ng mL1 (mean  SD), the time of max-
imum concentration (Tmax) was 66.0  36.9 min-
utes, and the approximated bioavailability of
detomidine was 34%. Pharmacokinetic parameters
are shown in Table 1.
The maximum sedation scores for each animal
and the overall levels of sedation (AUCsed) did not
differ between the treatments (Table 1). Briefly, for
the first 30 minutes after administration, CSS was
higher in the IV than in the GEL group. Thereafter,
CSS was higher in the GEL than in the IV group up to
210 minutes post administration (Fig. 2). Heart rate
decreased to a significantly lower level in the IV than
in the GEL group (Fig. 3).
Time from sedation to local anaesthetic adminis-
tration was 11 minutes (range 5–20 minutes) in IV
group and 38 minutes (range 25–55 minutes) in
GEL group. None of the calves substantially resisted
infiltration of the local anaesthetic nor reacted to hot
cauterization of horn buds. All recoveries were
eventless, and no adverse reactions were noted in
any of the animals. All calves were able to stand up
and walk at the end of the observation period. Rectal
temperatures did not differ between the treatments,
and hypothermia was not detected.
Discussion
Our results indicated that sublingual administration
of detomidine gel prior to infiltration of local
anaesthetics was an effective method to sedate
healthy calves for disbudding.
Venous blood from the oral mucosal membrane
drains via the jugular veins into the systemic
circulation, and thus during the absorption phase
of the drugs administered by this route, blood from
jugular vein may have substantially higher drug
concentrations than the mixed blood in systemic
circulation (Messenger et al. 2011). Therefore
plasma drug concentrations analyzed from the
jugular vein following sublingual administration
may not reflect systemic concentrations. We avoided
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this bias by collecting blood samples from the veins
of extremities (V. cephalica).
In a previous study (Salonen et al. 1989), the
pharmacokinetic profile of parenterally administered
detomidine in milking cows was close to that of adult
horses. In our study, the approximated bioavailabil-
ity of sublingually administered detomidine in calves
(34%) seemed to be relatively similar to the previ-
ously reported bioavailability in horses (22%)
(Kaukinen et al. 2011). Our study was not designed
to be a pharmacokinetic study, as our primary aim
was to evaluate clinical sedation. We collected
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Figure 1 Mean  SD plasma
detomidine concentrations after
sublingual (80 lg kg1, solid line)
and intravenous (30 lg kg1,
broken line) administration of
detomidine to calves. N = 10 per
group.
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Figure 2 Mean  SD composite
sedation scores (0–16 where 0 is
no sedation) after sublingual
(80 lg kg1, solid line) and
intravenous (30 lg kg1, broken
line) administration of detomidine
to calves. N = 10 per group.
*Statistically significant difference
(p < 0.05) between the groups.
Table 1 Pharmacokinetic parame-
ters and sedation scores (scale 0–16
where 0 = no sedation) after sub-
lingual (80 lg kg1) or intrave-
nous (30 lg kg1) of detomidine
administration
Detomidine 80
lg kg1 sublingually
Detomidine 30 lg kg1
intravenously
p-
value
Cmax (ng mL
1) 2.1  1.2 – –
Tmax (minutes) 66.0  36.9 – –
AUClast 226  110 252  127 0.62
Maximum sedation score 9.9  2.1 10.7  2.1 0.40
AUCsed 1026  477 784  209 0.16
All values mean  SD. N = 10 animals per group.
375 © 2014 The Authors Veterinary Anaesthesia and Analgesia published by John Wiley & Sons Ltd on behalf of
Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia and Analgesia, 41, 372–377
Sublingual detomidine in calves A-H Hokkanen et al.
plasma samples up to 4 hours after drug adminis-
tration, which probably affected the approximated
bioavailability. The elimination phase (ß-phase) was
not attained within the follow up time after sublin-
gual administration, and thus we could not extrap-
olate the plasma concentration versus time curve to
infinity.
As there was a risk that a fraction of the gel dose
could be swallowed, we carefully administered the
gel under the tongue. The volume of the gel was
small (<1 mL per calf) and it seemed to remain easily
in the oral cavity. Detomidine might undergo
extensive first-pass metabolism if swallowed, but
the amount of this metabolism is not known in
calves. Thus further studies are still needed about the
pharmacokinetics of detomidine in calves with this
administration route.
In general, the detomidine induced sedation was
equal in both treatment groups. However, maximum
sedation was reached earlier in the IV group than in
the GEL group. This suggested that 80 lg kg1 of
detomidine administered sublingually was equally
potent as 30 lg kg1 of IV administered detomidine.
The decrease in heart rate was less intense with
sublingual administration than with parenteral
administration, as reported earlier also for horses
(Malone & Clarke 1993; Kaukinen et al. 2011). Our
findings imply that sublingual administration of
detomidine would alleviate the decreases in heart
rate observed with parenteral administration of
detomidine. The efficacy and safety of detomidine
after sublingual administration to calves needs
further studies in various clinical indications.
In our study we measured regularly the rectal
temperature of the animals. If needed, we used
blankets to prevent hypothermia. Thus, hypother-
mia was not detected. It is important to monitor the
body temperature and prevent its reduction in
sedated animals as hypothermia affects drug metab-
olism and prolongs recovery.
We concluded that oromucosal detomidine gel is
an effective sedative for calves prior to infiltration of
local anaesthetics and to disbudding. This non-
invasive and user-friendly oromucosal sedation
method for calves could ease the use of local
anaesthetics.
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ela et al. (2001).
Appendix S2. Measurement of detomidine con-
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